LAMISIL (TERBINAFINE HYDROCHLORIDE) — FDA Approval NDA020749 (KARO HLTHCARE)
LAMISIL (TERBINAFINE HYDROCHLORIDE) — FDA Approval NDA020749 (KARO HLTHCARE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LAMISIL; Active ingredients: TERBINAFINE HYDROCHLORIDE; Application number: NDA020749.
| Brand name | LAMISIL |
|---|---|
| Active ingredients | TERBINAFINE HYDROCHLORIDE |
| Application number | NDA020749 |
| Sponsor | KARO HLTHCARE |
| Dosage form | SOLUTION |
| Route | TOPICAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19971017 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →